InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding InflaRx N.V. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 38 | +3 |
| Shares | 8.88M | 9.27M | +396.3K (+4.5%) |
| Value | $23.0M | $44.1M | +$21.1M (+91.9%) |
New holders (11)
Institutions that held InflaRx N.V. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,161,736 | $5.53M | 0.35% |
| Walleye Capital LLC | 530,432 | $2.52M | 0.08% |
| Invesco Ltd. | 159,396 | $759.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 100,706 | $479.0K | 0.09% |
| Kingsview Wealth Management, LLC | 71,870 | $342.0K | 0.01% |
| Citadel Advisors LLC | 56,074 | $267.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 27,053 | $129.0K | 0.00% |
| Commonwealth Equity Services, LLC | 10,100 | $48.0K | 0.00% |
| Cutler Group LP | 2,800 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 231 | $1.00K | 0.00% |
| FinTrust Capital Advisors, LLC | 100 | $0 | 0.00% |
Sold out (8)
Institutions that held InflaRx N.V. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| DAFNA Capital Management LLC | 600,000 | $1.55M |
| Great Point Partners LLC | 551,918 | $1.43M |
| Virtu Financial LLC | 26,016 | $67.0K |
| Two Sigma Securities, LLC | 22,553 | $58.0K |
| Occudo Quantitative Strategies LP | 10,548 | $27.0K |
| Simplex Trading, LLC | 3,846 | $11.0K |
| Royal Bank of Canada | 776 | $2.00K |
| Barclays PLC | 2 | $0 |